What is the patient re-identification risk from using de-identified clinical free text data for health research?
Authors: Elizabeth Ford, Simon Pillinger, Robert Stewart, Kerina Jones, Angus Roberts, Arlene Casey, Kasey Goddard, Goran Nenadic. Published online on 26 February, 2025. Link to full publication on Springer: What is the patient re-identification risk from using de-identified clinical free text data for health research? Abstract Important clinical information is recorded in free text in…
Akrivia Health Database—deep patient characterisation using a secondary mental healthcare dataset in England and Wales: cohort profile
Authors: Ana Todorovic, Philip Craig, Simon Pillinger, Panagiota Kontari, Sophie Gibbons, Luke Bryden, Tarso Franarin, Ceyda Uysal, Gloria Roque, Benjamin Fell Correspondence to Dr Ana Todorovic; ana.todorovic@akriviahealth.com Publication on BMJ Open: https://doi.org/10.1136/bmjopen-2024-088166 Abstract Purpose The Akrivia Health cohort was created to extract data from electronic health records in secondary mental health and dementia care services in England and Wales. The data are anonymised, structured and harmonised from…
The Akrivia Health Secure Data Access Service
Akrivia Heath curates a dataset of 5.1 million patients’ electronic health records (EHRs) from secondary care psychiatric healthcare organisations (HCOs) in England and Wales, available for research access. DOWNLOAD now by filling out the form below.
Treatment resistant depression: A comparative study of access, pathways, and outcomes between Caucasian and ethnic minority individuals
Background Treatment resistant depression (TRD) is considered when an individual fails to respond to two or more different antidepressants in adequate doses, duration and with adequate adherence within the same major depressive episode. Aim To examine the clinical profiles of TRD patients through data from electronic healthcare records and compare characteristics and treatment pathways of…
Using Electronic Health Records to Recruit Patients with Mild Cognitive Impairment for Clinical Trials
Clinical trials for psychotropic medication typically involve an elaborate screening process, where patients are required to meet complex inclusion and exclusion criteria to qualify for research participation. Screening criteria are usually envisaged with the aim to identify people who have a clear-cut diagnosis without many otherwise frequent comorbidities. However, psychiatric patients often exhibit traits present…
A data-driven approach to clinical trial patient samples
Ana Todorovic, Sophie Gibbons, Philip Craig, Benjamin Fell MQDataMind2023_Poster_ATDownload IntroductionPsychotropic drug trials often involve a substantial period of patient recruitment. Psychiatrists typically use their own judgment to sequentially approach patients who might fulfill complex inclusion and exclusion criteria. However, information already present in patient records can also be used to constrain who is approached for…
